Area families affected by Alzheimer’s disease will benefit from funds raised at the 10th Annual Alzheimer’s Pro-Am Golf Tournament July 14 - 15. Sponsored by the Alzheimer’s Association - Quincy Area Branch, the event kicks off with a cocktail reception, dinner and auction at Mark Twain Casino on Thursday, July 14.
An unknown ingredient in coffee teams up with caffeine to stimulate blood levels of a critical protein called GCSF, short for granulocyte-colony stimulating factor, that appears to put off the development of Alzheimer’s disease. These were the conclusions of a team from the University of South Florida (USF), whose members conducted their research on mice and describe the work in a paper …
An unknown ingredient in coffee teams up with caffeine to stimulate blood levels of a critical protein called GCSF, short for granulocyte-colony stimulating factor, that appears to put off the development of Alzheimer’s disease.
An Alzheimer’s disease “Wall of Remembrance” memorial will be dedicated at East Lawn Memorial Park on July 9, as part of an annual East Sacramento event to raise awareness on behalf of local Alzheimer’s agencies. The memorial dedication is scheduled for 10:30 a.m.
An Alzheimer’s disease “Wall of Remembrance” memorial will be dedicated at East Lawn Memorial Park on July 9, as part of an annual East Sacramento event to raise awareness on behalf of local Alzheimer’s agencies. The memorial dedication is scheduled for 10:30 a.m.
Jack Agueros, who directed El Museo del Barrio for almost a decade, has forgotten that he is the author of four books, a handful of plays, sonnets and satiric psalms about poverty and social inequality.
( University of Gothenburg ) Researchers at the Sahlgrenska Academy, University of Gothenburg, have identified a series of novel proteins in human cerebrospinal fluid.
While high-profile cases have since brought Alzheimer’s into the national spotlight, local health-care professionals say the disease still comes with a stigma and misconceptions that can delay much-needed treatment.
Disease-related gene controls clearance of plaque protein
A new study shows that guzzling caffeinated coffee may actually be good for our brains. In fact, it may help keep Alzheimer’s at bay.
Remember a diagnosis does not mean your loved one cannot make decisions about the future.
Developer Abe Atiyeh targets former office building for latest project. A construction company owned by developer Abraham Atiyeh wants to turn a Forks Township office building into an Alzheimer’s personal care home.
Like your morning cup of Joe? Your brain might also appreciate the lift.
Alzheimer’s, the degenerative brain disorder that disrupts memory, thought and behavior, is devastating to both patients and loved ones. According to the Alzheimer’s Association, one in eight Americans over the age of 65 suffers from the disease.
The treatment procedure that dramatically reverses Alzheimer’s cognitive deficits is for the first time being taught to lay caregivers. New free training courses teaching perispinal injection technique are being offered by Neurological Wellness Center.Harmony, CA (PRWEB) June 28, 2011 Since 2006 when Medscape published the first pilot study documenting improvements in memory and cognitive …
23andMe and Genentech are conducting research to uncover the genomic underpinnings of Alzheimer’s disease with the hopes of incorporating their findings in the development of a preventative drug.
SACRAMENTO — The UC Davis Alzheimer’s Disease Center, which investigates the causes and trajectories of cognitive aging and risk for late-life dementia, has received renewed grant funding of $6.9 million from the National Institute on Aging of the National Institutes of Health.
Alzheimer’s disease drug development company Curaxis Pharmaceutical (OTC:CURX) is overhauling its operations with a swap out of both the management team and the board of directors. Taking over as chairman of Curaxis’s board and interim CEO is Timothy Wright, who leaves global healthcare products giant Covidien (NYSE:COV) where he was president of the company’s pharmaceuticals division.
An extract found in cinnamon bark, called CEppt, contains properties that can inhibit the development of Alzheimer’s disease, according to researchers.
Molecular inhibitors that target specific proteins may prevent diseases from forming.